Register information Protection certificate

DE file number : 12 2019 000 027.5 (Status: pending/in force, Query started: December 15, 2025)

Please note: This English version is a non-binding translation of the German register excerpt. Only the German version of the register excerpt is legally binding.

Master data
INIDCriterionFieldContent
Type of IP rightSARTProtection certificate
StatusSTPending/in force
21DE file number DAKZ12 2019 000 027.5
UseVZMedicinal products
95Product nameTIEZKombination von Vaborbactam, oder ein Salz oder ein Hydrat davon, und Meropenem, oder ein Salz oder ein Hydrat davon, insbesondere Meropenemtrihydrat
54Title of basic patentTIGZZYKLISCHE BORONSÄUREESTERDERIVATE UND THERAPEUTISCHE VERWENDUNGEN DAVON
51IPC main classICM
(ICMV)		 C07F 5/02 (2006.01)
51IPC secondary class(es)ICS
(ICSV)		 A61K 31/69 (2006.01), A61P 31/04 (2006.01)
94Start of term of protectionLBAug 9, 2031
94End of term of protectionLENov 22, 2033
22DE application dateDATMar 28, 2019
Date of publication of application for a certificateOTMay 16, 2019
Date of publication of grant of certificatePETMay 25, 2022
71/73Applicant/ownerINHMelinta Therapeutics, Inc., 44 Whippany Road, Suite 280, 07960 Morristown, NJ, US
74RepresentativeVTRAbitz & Partner Patentanwälte mbB, 81925 München, DE
Address for service Abitz & Partner Patentanwälte mbB, 81628 München, DE
Due dateFT
FG		Aug 31, 2031
Annual fee for the 21st year Patent fees
Patent division in charge 44
68DE file number of basic patentGAKZ60 2011 050 223.9
68EP file number of basic patentGEAKZ11 81 6882.2
43Date of first publicationEVTMay 16, 2019
92
92
92
Domestic authorisationGIS
GIN
GIT
Europäische Kommission
EU/1/18/1334
2018-11-20
93
93
93
93
EU authorisationGES
GEC
GEN
GET
Europäische Kommission
EU
EU/1/18/1334
2018-11-20
Date of the first transfer into DPMAregisterEREGTMay 16, 2019
Date of the (most recent) update in DPMAregisterREGTJul 20, 2024
(Show all update days)(Hide all update days)
  • Jul 20, 2024
    • St.36: changed (technical change)
  • Nov 25, 2023; Apr 30, 2022; Apr 21, 2022; Feb 11, 2022; Aug 7, 2021; Aug 6, 2020; Jul 16, 2019
    • Historical data not available for this/these date(s)
  • May 16, 2019
    • Date of the first transfer into DPMAregister
Procedural data
No.Kind of procedureLegal statusDate of legal/procedural statusDate of first publicationAlle Details anzeigen
1 Supplementary protection certificate procedure Application for supplementary protection certificate effectively filed Apr 9, 2019 May 16, 2019 Details anzeigen
2 New applicant/owner details New applicant/owner details Aug 5, 2020  Details anzeigen
3 New applicant/owner details New applicant/owner details Aug 6, 2021  Details anzeigen
4 Supplementary protection certificate procedure Decision to grant supplementary protection certificate by Patent Division Feb 10, 2022  Details anzeigen
5 Supplementary protection certificate procedure Supplementary protection certificate granted Mar 23, 2022 May 25, 2022 Details anzeigen
View procedures Supplementary protection certificate procedure (No.: 1)
INIDCriterionFieldContent Close details
Type of procedureVARTProtection certificate procedure
Legal/procedural statusVSTApplication for supplementary protection certificate effectively filed
Date of legal/procedural statusVSTTApr 9, 2019
Issue numberHN20
YearPJ2019
Publication dateVTMay 16, 2019
Type of publicationPARTBibliographic data
PartHTPart 7
68DE file number of basic patentGAKZ60 2011 050 223.9
68EP file number of basic patentGEAKZ11 81 6882.2
View procedures New applicant/owner details (No.: 2)
INIDCriterionFieldContent Close details
Type of procedureVARTNew applicant/owner details
Legal/procedural statusVSTNew applicant/owner details
Date of legal/procedural statusVSTTAug 5, 2020
71/73Applicant/ownerINHMelinta Therapeutics, Inc., Morristown, NJ, US
71/73Previous applicant/ownerINHFRempex Pharmaceuticals, Inc., Lincolnshire, IL, US
Date of update of the procedureREGTAug 6, 2020
View procedures New applicant/owner details (No.: 3)
INIDCriterionFieldContent Close details
Type of procedureVARTNew applicant/owner details
Legal/procedural statusVSTNew applicant/owner details
Date of legal/procedural statusVSTTAug 6, 2021
71/73Applicant/ownerINHMelinta Therapeutics, Inc., 07960 Morristown, NJ, US
71/73Previous applicant/ownerINHFMelinta Therapeutics, Inc., Morristown, NJ, US
Date of update of the procedureREGTAug 7, 2021
View procedures Supplementary protection certificate procedure (No.: 4)
INIDCriterionFieldContent Close details
Type of procedureVARTProtection certificate procedure
Legal/procedural statusVSTDecision to grant supplementary protection certificate by Patent Division
Date of legal/procedural statusVSTTFeb 10, 2022
Date of update of the procedureREGTFeb 11, 2022
View procedures Supplementary protection certificate procedure (No.: 5)
INIDCriterionFieldContent Close details
Type of procedureVARTProtection certificate procedure
Legal/procedural statusVSTSupplementary protection certificate granted
Date of legal/procedural statusVSTTMar 23, 2022
Issue numberHN21
YearPJ2022
Publication dateVTMay 25, 2022
Type of publicationPARTBibliographic data
PartHTPart 7
Date of update of the procedureREGTApr 30, 2022